project id: TCGA-HNSC; case submitter id: TCGA-MZ-A6I9; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.97; rna integrity number: 8.8; age at index: 68; days to birth: -24939; days to death: 489; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; age at diagnosis: 24939; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 254.0; icd 10 code: C10.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Oropharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Oropharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 0.7671232876712328; pack years smoked: 14.0; years smoked: 14.0; is ffpe: false; composition: Not Reported; days to collection: 156; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-MZ-A6I9-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 1.0; percent necrosis: 4.0; percent neutrophil infiltration: 1.0; percent normal cells: 20.0; percent stromal cells: 30.0; percent tumor cells: 46.0; percent tumor nuclei: 70.0;